Shuttle Pharmaceuticals Holdings, Inc. Cash Flow Statement

Cash Flow Statement Dec2021 Dec2022 Dec2023 Dec2024
Operating Activities
Net Income -1.15M-3.03M-6.59M-8.86M
Depreciation and Depletion 0.01M0.01M0.01M0.01M
Share-based Compensation 0.91M0.40M0.18M0.26M
Gains from Investment Securities -0.58M-0.09M0.00M0.03M
Cash from Operations -0.30M-2.71M-5.58M-7.33M
Depreciation, Depletion & Amortization
Amortizatization of Intangibles 0.05M0.89M2.12M1.08M
Depreciation & Amortization (CF) 0.01M0.01M0.01M0.01M
Change in Working Capital
Change in Receivables -0.21M
Change in Account Payables 0.31M-0.38M
Change in Accured Expenses 0.05M-0.38M0.17M0.31M
Other Working Capital Changes -0.06M0.16M-0.05M0.18M
Investing Activities
Capital Expenditures 0.02M
Change in Acquisitions & Divestments 0.19M2.96M
Cash from Investing Activities -2.83M2.92M
Financing Activities
Other financing activities 0.34M0.24M
Cash from Financing Activities 0.69M10.62M2.57M3.76M
Additional items
Change in Cash 0.39M7.91M-5.84M-0.66M
Beginning Cash Balance -0.39M-7.91M5.84M0.66M
Free Cash Flow -0.30M-2.71M-5.60M-7.33M
Net Cash Flow 0.39M7.91M-5.84M-0.66M